Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study observes how inhaled drug works for Lung-Related high blood pressure

NCT ID NCT07478094

First seen Mar 17, 2026 · Last updated May 25, 2026 · Updated 16 times

Summary

This study looks back at medical records of 50 adults with pulmonary hypertension caused by chronic lung disease who were treated with inhaled iloprost. Researchers want to see how patients' risk levels change over time and track events like hospital stays. No new treatments or visits are involved—just gathering existing data to learn more about this drug's real-world effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION DUE TO LUNG DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo

    São Paulo, São Paulo, 05403-900, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.